Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
American Journal of Transplantation
Journal
Overview
Identity
Overview
Publication Venue For
First clinical-grade porcine kidney xenotransplant using a human decedent model
. 22:1037-1053.
2022
Prognostic value of silent myocardial infarction in patients with chronic kidney disease after kidney transplantation
. 22:1115-1122.
2022
COVID-19 and transplantation—Data censoring
2022
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic
. 22:279-288.
2022
Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations
2022
Sex and organ-specific risk of major adverse renal or cardiac events in solid organ transplant recipients with COVID-19
. 22:245-259.
2022
Telemedicine services for living kidney donation: A US survey of multidisciplinary providers
2022
Bioenergetic maladaptation and release of HMGB1 in calcineurin inhibitor-mediated nephrotoxicity
. 21:2964-2977.
2021
Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers
. 21:3034-3042.
2021
The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients
. 21:2937-2949.
2021
COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative
. 21:2740-2748.
2021
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action
. 21:1754-1764.
2021
i-IFTA and chronic active T cell–mediated rejection: A tale of 2 (DeKAF) cohorts
. 21:1866-1877.
2021
Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation
. 21:1612-1621.
2021
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
. 21:475-483.
2021
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement
. 21:460-474.
2021
Clinical trials of pediatric cardiac xenotransplantation
. 21:433-434.
2021
Competing risks and the risks of children and adults competing for livers
. 21:13-14.
2021
Inflammation in areas of fibrosis: The DeKAF prospective cohort
. 20:2509-2521.
2020
Transplant physician and surgeon compensation: A sample framework accounting for nonbillable and value-based work
. 20:641-652.
2020
Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results
. 20:617-619.
2020
Tackling the weight list problem
. 20:329-330.
2020
Get on with it!—A novel allocation strategy to reduce kidney discards
. 19:2971-2972.
2019
Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups
. 19:2795-2804.
2019
WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure
. 19:2833-2845.
2019
Patient-reported outcome measures for life participation in kidney transplantation: A systematic review
. 19:2306-2317.
2019
The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population
. 19:2262-2273.
2019
Variation in use of procurement biopsies and its implications for discard of deceased donor kidneys recovered for transplantation
. 19:2241-2251.
2019
Time for reform in transplant program–specific reporting: AST/ASTS transplant metrics taskforce
. 19:1888-1895.
2019
Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant
. 19:1806-1819.
2019
Long-term follow-up of the DeKAF cross-sectional cohort study
. 19:1432-1443.
2019
Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA
. 19:1597-1598.
2019
Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients
. 19:1218-1223.
2019
Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor—A multicenter analysis
. 19:475-487.
2019
Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications
. 19:123-131.
2019
Can you hear me now? Patient preferences for evaluating kidney transplant centers
. 18:2624.
2018
Current opinions in organ allocation
. 18:2625-2634.
2018
Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act
. 18:2579-2586.
2018
Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation
. 18:2483-2495.
2018
Response to “It is time to revise the kidney allocation system to restore the pediatric advantage”
. 18:2367.
2018
Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation
. 18:2189-2199.
2018
Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates
. 18:1947-1953.
2018
Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system
. 18:1690-1698.
2018
Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States
. 18:1494-1501.
2018
Response to: Regarding “HIV protease inhibitors and mortality following kidney transplantation”
. 18:1571.
2018
Human polyomavirus-7–associated eruption successfully treated with acitretin
. 18:1278-1284.
2018
Late graft failure after kidney transplantation as the consequence of late versus early events
. 18:1158-1167.
2018
Assessing emergency department utilization in the era of population health
. 18:777-778.
2018
Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study
. 18:650-658.
2018
Urologic malignancies in kidney transplantation
. 18:13-22.
2018
Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients
. 17:3114-3122.
2017
The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis
. 17:3123-3130.
2017
B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function
. 17:2627-2639.
2017
Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept
. 17:2712-2719.
2017
PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force
. 17:2546-2558.
2017
Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial
. 17:2640-2649.
2017
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors
. 17:1823-1832.
2017
Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index
. 17:1540-1548.
2017
The Influence of Race and Common Genetic Variations on Outcomes After Pediatric Heart Transplantation
. 17:1525-1539.
2017
Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model
. 17:1193-1203.
2017
Ureteral Obstruction and New Groin Pain in a Kidney Transplant Recipient
. 17:1139-1141.
2017
Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients
. 17:173-179.
2017
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
. 17:28-41.
2017
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
. 16:3468-3478.
2016
Splenic irradiation for the treatment of severe antibody-mediated rejection
. 16:3041-3045.
2016
Anti–Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation
. 16:2483-2486.
2016
Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant Recipients
. 16:2377-2383.
2016
Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus
. 16:2368-2376.
2016
Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation
. 16:2342-2351.
2016
Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection
. 16:1456-1464.
2016
Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients
. 16:1465-1473.
2016
Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk
. 16:833-840.
2016
Presentation and outcomes of C4d-negative antibody-mediated rejection after kidney transplantation
. 16:213-220.
2016
Where the Sun shines: Industry's payments to transplant surgeons
. 16:292-300.
2016
First report on the OPTN national variance: Allocation of A
2
/A
2
B deceased donor kidneys to blood group B increases minority transplantation
. 15:3134-3142.
2015
Hospital-onset Clostridium difficile infection among solid organ transplant recipients
. 15:2970-2977.
2015
Longitudinal Studies of a B Cell-Derived Signature of Tolerance in Renal Transplant Recipients
. 15:2908-2920.
2015
Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients
. 15:2096-2104.
2015
Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation
. 15:2188-2196.
2015
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure
. 15:1615-1622.
2015
Solid organ transplantation from hepatitis B virus-positive donors: Consensus guidelines for recipient management
. 15:1162-1172.
2015
A pilot trial targeting the icos-icos-l pathway in nonhuman primate kidney transplantation
. 15:984-992.
2015
Loss of pediatric kidney grafts during the "high-risk age window": Insights from pediatric liver and simultaneous liver-kidney recipients
. 15:445-452.
2015
Quantifying renal allograft loss following early antibody-mediated rejection
. 15:489-498.
2015
The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs
. 15:541-546.
2015
Frailty and mortality in kidney transplant recipients
. 15:149-154.
2015
Emotional well-being of living kidney donors: Findings from the RELIVE study
. 14:2535-2544.
2014
Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation
. 14:459-465.
2014
Kidneys at higher risk of discard: Expanding the role of dual kidney transplantation
. 14:404-415.
2014
Preoperative plasma club (Clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation
. 14:446-452.
2014
To transplant a kidney with the heart or not - That is the real question
. 14:253-254.
2014
A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation
. 14:1191-1198.
2014
Epidemiology of invasive mold infections in lung transplant recipients
. 14:1328-1333.
2014
Hemorrhagic shock one month following uncomplicated liver transplantation
. 14:1461-1463.
2014
Quantifying the risk of incompatible kidney transplantation: A multicenter study
. 14:1573-1580.
2014
Role of left ventricular assist devices in assessment of patients for combined heart-kidney transplantation
. 14:1946-1947.
2014
Transmission of Balamuthia mandrillaris through solid organ transplantation: Utility of organ recipient serology to guide clinical management
. 14:1417-1424.
2014
Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primates
. 13:3085-3093.
2013
What liver transplant outcomes can be expected in the uninsured who become insured via the affordable care act?
. 13:1533-1540.
2013
Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older - United States, 2013
. 13:1354-1363.
2013
Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection
. 13:1075-1079.
2013
The aggressive phenotype revisited: Utilization of higher-risk liver allografts
. 13:936-942.
2013
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion
. 13:320-328.
2013
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades
. 13:390-398.
2013
A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients
. 12:3061-3068.
2012
Erratum: A realistic proposal-incentives may increase donation - We need trials now! (American Journal of Transplantation (2012) 12 (1957-1958) DOI:10.1111/j.1600-6143.2012.04117.x)
. 12:2261.
2012
Report of a consensus conference on transplant program quality and surveillance
. 12:1988-1996.
2012
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival
. 12:1924-1928.
2012
Organ donation and moyamoya disease
. 12:1353-1355.
2012
A response to child-to-parent donationa-consideration of age and ethnicity
. 12:503.
2012
Counseling patients for kidney transplantation: Awkward conversations?
. 12:273-274.
2012
A realistic proposal - Incentives may increase donation - We need trials now!
. 12:1957-1958.
2012
The PROMISE study: A phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de Novo kidney transplantation
. 11:2675-2684.
2011
Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis
. 11:2517-2522.
2011
The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation
. 11:2197-2204.
2011
Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation
. 11:1650-1655.
2011
Elevated plasma Clara cell secretory protein concentration is associated with high-grade primary graft dysfunction
. 11:561-567.
2011
Living donor nephrectomy: Understanding long-term risk in minority populations
. 10:2574-2576.
2010
Association of race and socioeconomic position with outcomes in pediatric heart transplant recipients
. 10:2116-2123.
2010
Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access
. 10:2154-2160.
2010
Inflammation in areas of tubular atrophy in kidney allograft biopsies: A potent predictor of allograft failure
. 10:2066-2073.
2010
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival: Special feature
. 10:1090-1107.
2010
Proinflammatory events and HLA antibodies.
. 10:956.
2010
Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: Preliminary data from the DeKAF study
. 10:315-323.
2010
Pathological and clinical characterization of the 'Troubled transplant': Data from the DeKAF study
. 10:324-330.
2010
Candida in solid organ transplant recipients
. 9.
2009
Impact of medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation
. 9:2785-2791.
2009
Long-term management of the liver transplant patient: Recommendations for the primary care doctor: Special feature
. 9:1988-2003.
2009
Use of cardioprotective medications in kidney transplant recipients
. 9:1811-1815.
2009
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: The opticept trial
. 9:1607-1619.
2009
Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center: Brief communication
. 9:1671-1673.
2009
Transplant tourism and unregulated black-market trafficking of organs
. 9:1484.
2009
Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate
. 9:1243-1248.
2009
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation
. 9:389-396.
2009
Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody
. 9:2136-2139.
2009
The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection
. 9:231-235.
2009
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: Preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics
. 8:1711-1718.
2008
Effect modification in liver allografts with prolonged cold ischemic time
. 8:658-666.
2008
Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation
. 7:2573-2578.
2007
Heart retransplantation
. 7:2075-2081.
2007
Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation
. 7:1797-1807.
2007
Adeno-associated viral vector-mediated interleukin-10 prolongs allograft survival in a rat kidney transplantation model
. 7:1112-1120.
2007
Must all living donor compensation be viewed as valuable consideration? [2]
. 7:1309-1310.
2007
The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection
. 7:842-846.
2007
Cold ischemia time and allograft outcomes in live donor renal transplantation: Is live donor organ transport feasible?
. 7:99-107.
2007
Limiting financial disincentives in live organ donation: A rational solution to the kidney shortage
. 6:2548-2555.
2006
The conspicuous costs of more of the same
. 6:1503-1504.
2006
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: Reanalysis of the multicenter trial
. 6:993-997.
2006
Invasive fungal infections in low-risk liver transplant recipients: A multi-center prospective observational study
. 6:386-391.
2006
Acute Graft versus host disease after liver transplantation: Patterns of lymphocyte chimerism
. 5:2968-2973.
2005
Understanding the influence of ethnicity on renal allograft survival
. 5:2603-2604.
2005
Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts
. 5:2248-2252.
2005
Kidneys from deceased donors: Maximizing the value of a scarce resource
. 5:1725-1730.
2005
Long-term deterioration of kidney allograft function
. 5:1405-1414.
2005
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn International Transplant Tumor Registry experience
. 5:775-780.
2005
Thoracic organ transplantation in the United States, 1994-2003.
. 5:934-949.
2005
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression
. 5:356-365.
2005
Thoracic organ transplantation in the United States, 1994-2003
. 5:934-949.
2005
Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4
+
TCR Tg T cells specific for a defined allopeptide
. 4:1762-1768.
2004
Calcium oxalate deposition in renal allografts: Morphologic spectrum and clinical implications
. 4:1338-1344.
2004
Whither Living Donors?
. 4:2-3.
2004
Equivalent Pharmacokinetics of Mycophenolate Mofetil in African-American and Caucasian Male and Female Stable Renal Allograft Recipients
. 3:1581-1586.
2003
Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: Effective CMV prevention following daclizumab induction
. 3:492-496.
2003
Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation
. 3:484-491.
2003
Determinants of cardiovascular mortality after renal transplantation: A role for cytomegalovirus?
. 3:79-81.
2003
Diabetes mellitus after kidney transplantation
. 3:512-513.
2003
Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C
. 3:626-630.
2003
The report of a national conference on the wait list for kidney transplantation
. 3:775-785.
2003
Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy
. 2:983-988.
2002
Use of preserved vascular homografts in liver transplantation: Hepatic artery aneurysms and other complications
. 2:471-475.
2002
The general public's concerns about clinical risk in live kidney donation
. 2:186-193.
2002
Addressing minority issues in renal transplantation: Is more equitable access an achievable goal?
. 2:1-3.
2002
Identity
International Standard Serial Number (issn)
1600-6135
Electronic International Standard Serial Number (eissn)
1600-6143